IL6 and breast carcinoma: Moreover, resistance exercise in breast cancer patients undergoing treatment inhibited the increase in IL-6 and IL-6/interleukin-1 receptor antagonist (IL-1ra) ratio, which were associated with high levels of physical fatigue and pain in the control (non-exercising) group [108].